Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dyne Therapeutics, Inc.

13.38
+0.38002.92%
Volume:2.52M
Turnover:33.68M
Market Cap:1.90B
PE:-3.46
High:13.50
Open:13.00
Low:12.86
Close:13.00
52wk High:46.26
52wk Low:6.36
Shares:142.26M
Float Shares:118.00M
Volume Ratio:1.03
T/O Rate:2.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8694
EPS(LYR):-3.3716
ROE:-61.32%
ROA:-35.45%
PB:3.33
PE(LYR):-3.97

Loading ...

Dyne Therapeutics Inc : Chardan Capital Markets Cuts Target Price to $38 From $50

THOMSON REUTERS
·
Jul 29

Chardan Capital Sticks to Its Buy Rating for Dyne Therapeutics (DYN)

TIPRANKS
·
Jul 29

Dyne Therapeutics Q2 EPS $(0.97), Inline

Benzinga
·
Jul 29

Dyne Therapeutics Q2 2025: Reports R&D Expenses Rise to $99.2M from $62.3M in Q2 2024, Cash Position Bolstered by $215.2M Offering

Reuters
·
Jul 29

Dyne Therapeutics Secures Breakthrough Therapy Designation from FDA for DYNE-101 in Treatment of Myotonic Dystrophy Type 1

Reuters
·
Jul 29

Dyne Therapeutics Inc - Extends Cash Runway Into Q3 2027

THOMSON REUTERS
·
Jul 29

Dyne Therapeutics Q2 Operating Expenses USD 115.791 Million

THOMSON REUTERS
·
Jul 29

Dyne Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights

GlobeNewswire
·
Jul 29

Satellos Bioscience Inc. Appoints Dr. Wildon Farwell as New Chief Medical Officer, Succeeding Dr. Jordan Dubow

Reuters
·
Jul 16

Dyne Therapeutics CEO buys $911K in common stock

TIPRANKS
·
Jul 16

John Cox, CEO & President, Reports Acquisition of Common Shares in Dyne Therapeutics Inc

Reuters
·
Jul 16

J.P. Morgan Keeps Their Hold Rating on Dyne Therapeutics (DYN)

TIPRANKS
·
Jul 16

Dyne Therapeutics Is Maintained at Neutral by JP Morgan

Dow Jones
·
Jul 16

Dyne Therapeutics price target lowered to $41 from $46 at Evercore ISI

TIPRANKS
·
Jul 12

RBC Capital Sticks to Their Buy Rating for Dyne Therapeutics (DYN)

TIPRANKS
·
Jul 08

Dyne Therapeutics Raises $230 Million From Shares Offering

MT Newswires Live
·
Jul 03

Press Release: Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

Dow Jones
·
Jul 03

Bernstein Keeps Their Hold Rating on Dyne Therapeutics (DYN)

TIPRANKS
·
Jul 02

Dyne Therapeutics Announces $200M Public Offering

TIPRANKS
·
Jul 02

BUZZ-U.S. STOCKS ON THE MOVE-Energy stocks, Apple, Vertex

Reuters
·
Jul 02